108 related articles for article (PubMed ID: 22178070)
1. Artificial neural networks for closed loop control of in silico and ad hoc type 1 diabetes.
Fernandez de Canete J; Gonzalez-Perez S; Ramos-Diaz JC
Comput Methods Programs Biomed; 2012 Apr; 106(1):55-66. PubMed ID: 22178070
[TBL] [Abstract][Full Text] [Related]
2. Diabetes technology and treatments in the paediatric age group.
Shalitin S; Peter Chase H
Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
[TBL] [Abstract][Full Text] [Related]
3. Neural predictive controller for insulin delivery using the subcutaneous route.
Trajanoski Z; Wach P
IEEE Trans Biomed Eng; 1998 Sep; 45(9):1122-34. PubMed ID: 9735562
[TBL] [Abstract][Full Text] [Related]
4. Neural network modeling and control of type 1 diabetes mellitus.
El-Jabali AK
Bioprocess Biosyst Eng; 2005 Apr; 27(2):75-9. PubMed ID: 15578231
[TBL] [Abstract][Full Text] [Related]
5. An insulin infusion advisory system based on autotuning nonlinear model-predictive control.
Zarkogianni K; Vazeou A; Mougiakakou SG; Prountzou A; Nikita KS
IEEE Trans Biomed Eng; 2011 Sep; 58(9):2467-77. PubMed ID: 21622071
[TBL] [Abstract][Full Text] [Related]
6. A gain-scheduling model predictive controller for blood glucose control in type 1 diabetes.
Abu-Rmileh A; Garcia-Gabin W
IEEE Trans Biomed Eng; 2010 Oct; 57(10):2478-84. PubMed ID: 19846371
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of insulin lispro in type 2 diabetes during closed-loop insulin delivery.
Ruan Y; Thabit H; Kumareswaran K; Hovorka R
Comput Methods Programs Biomed; 2014 Nov; 117(2):298-307. PubMed ID: 25092225
[TBL] [Abstract][Full Text] [Related]
8. Modeling, identification and nonlinear model predictive control of type I diabetic patient.
Schlotthauer G; Gamero LG; Torres ME; Nicolini GA
Med Eng Phys; 2006 Apr; 28(3):240-50. PubMed ID: 15964233
[TBL] [Abstract][Full Text] [Related]
9. Physiologic insulin delivery with insulin feedback: a control systems perspective.
Palerm CC
Comput Methods Programs Biomed; 2011 May; 102(2):130-7. PubMed ID: 20674062
[TBL] [Abstract][Full Text] [Related]
10. Feedforward-feedback multiple predictive controllers for glucose regulation in type 1 diabetes.
Abu-Rmileh A; Garcia-Gabin W
Comput Methods Programs Biomed; 2010 Jul; 99(1):113-23. PubMed ID: 20430467
[TBL] [Abstract][Full Text] [Related]
11. Fuzzy-based controller for glucose regulation in type-1 diabetic patients by subcutaneous route.
Campos-Delgado DU; Hernández-Ordoñez M; Femat R; Gordillo-Moscoso A
IEEE Trans Biomed Eng; 2006 Nov; 53(11):2201-10. PubMed ID: 17073325
[TBL] [Abstract][Full Text] [Related]
12. SMARTDIAB: a communication and information technology approach for the intelligent monitoring, management and follow-up of type 1 diabetes patients.
Mougiakakou SG; Bartsocas CS; Bozas E; Chaniotakis N; Iliopoulou D; Kouris I; Pavlopoulos S; Prountzou A; Skevofilakas M; Tsoukalis A; Varotsis K; Vazeou A; Zarkogianni K; Nikita KS
IEEE Trans Inf Technol Biomed; 2010 May; 14(3):622-33. PubMed ID: 20123578
[TBL] [Abstract][Full Text] [Related]
13. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.
Weinzimer SA; Steil GM; Swan KL; Dziura J; Kurtz N; Tamborlane WV
Diabetes Care; 2008 May; 31(5):934-9. PubMed ID: 18252903
[TBL] [Abstract][Full Text] [Related]
14. A fuzzy logic based closed-loop control system for blood glucose level regulation in diabetics.
Ibbini MS; Masadeh MA
J Med Eng Technol; 2005; 29(2):64-9. PubMed ID: 15804854
[TBL] [Abstract][Full Text] [Related]
15. A simulation study of an inverse controller for closed- and semiclosed-loop control in type 1 diabetes.
Rodríguez-Herrero A; Pérez-Gandía C; Rigla M; de Leiva A; Gómez EJ; Hernando ME
Diabetes Technol Ther; 2010 Feb; 12(2):95-104. PubMed ID: 20105038
[TBL] [Abstract][Full Text] [Related]
16. Induced L₂-norm minimization of glucose-insulin system for Type I diabetic patients.
Kovács L; Benyó B; Bokor J; Benyó Z
Comput Methods Programs Biomed; 2011 May; 102(2):105-18. PubMed ID: 20674065
[TBL] [Abstract][Full Text] [Related]
17. On-line adaptive algorithm with glucose prediction capacity for subcutaneous closed loop control of glucose: evaluation under fasting conditions in patients with Type 1 diabetes.
Schaller HC; Schaupp L; Bodenlenz M; Wilinska ME; Chassin LJ; Wach P; Vering T; Hovorka R; Pieber TR
Diabet Med; 2006 Jan; 23(1):90-3. PubMed ID: 16409572
[TBL] [Abstract][Full Text] [Related]
18. The development of wearable-type artificial endocrine pancreas and its usefulness in glycaemic control of human diabetes mellitus.
Shichiri M; Kawamori R; Hakui N; Asakawa N; Yamasaki Y; Abe H
Biomed Biochim Acta; 1984; 43(5):561-8. PubMed ID: 6477542
[TBL] [Abstract][Full Text] [Related]
19. Closing the loop: the adicol experience.
Hovorka R; Chassin LJ; Wilinska ME; Canonico V; Akwi JA; Federici MO; Massi-Benedetti M; Hutzli I; Zaugg C; Kaufmann H; Both M; Vering T; Schaller HC; Schaupp L; Bodenlenz M; Pieber TR
Diabetes Technol Ther; 2004 Jun; 6(3):307-18. PubMed ID: 15198833
[TBL] [Abstract][Full Text] [Related]
20. Closed-loop subcutaneous insulin infusion algorithm with a short-acting insulin analog for long-term clinical application of a wearable artificial endocrine pancreas.
Shimoda S; Nishida K; Sakakida M; Konno Y; Ichinose K; Uehara M; Nowak T; Shichiri M
Front Med Biol Eng; 1997; 8(3):197-211. PubMed ID: 9444512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
